Site Search

Share

X

Search Results

Expand Access to Biomarker Testing in Nevada

Welcome!Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Nevadans can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of ...

Expand Access to Biomarker Testing in Washington

Welcome! Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Washingtonians can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of ...

Expand Access to Biomarker Testing in Massachusetts

Biomarker testing helps connect patients with the right treatment at the right time- and ACS CAN is committed to making sure every Massachusetts ... benefit from this transformational tool.   Across the country, more than 20 states have passed bipartisan legislation to enhance access to biomarker testing. Massachusetts should pass H.4339 and S.809 to guarantee coverage of evidence-based biomarker testing, so that every patient has a fair ...

Understanding Provider Utilization of Cancer Biomarker Testing

Biomarker testing is an important step to accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. However, not all communities are benefitting from the latest advancements in biomarker testing and precision medicine. ACS CAN is working to dismantle barriers that prevent patients from benefiting from biomarker testing and precision ...

Understanding Provider Utilization of Cancer Biomarker Testing

Biomarker testing is an important step to accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. However, not all communities are benefitting from the latest advancements in biomarker testing and precision medicine. ACS CAN is working to dismantle barriers that prevent patients from benefiting from biomarker testing and precision ...

Senate Committee Passes Biomarker Testing Coverage Bill

NASHVILLE, Tenn. – On Tuesday, April 7, Senate Bill 0435 to expand coverage of biomarker testing in Tennessee overcame a significant hurdle, passing the Senate Commerce and Labor Committee. SB0435 would expand coverage of biomarker testing for patients enrolled in  state employee health insurance plans and TennCare. American Cancer Society Cancer Action Network (ACS ...

Mississippi Senate Passes Biomarker Testing Coverage Bill

JACKSON, Miss. – The Mississippi Senate passed Senate Bill 2694 Wednesday, February 11, paving the way for increased access to biomarker testing for patients across the Magnolia State. Biomarker testing is a key tool used by physicians to identify the most effective treatments for cancer and other diseases. “In the case of a ...

Tennessee House Passes Biomarker Testing Coverage Bill

NASHVILLE, Tenn. – On Monday, March 30, the Tennessee House unanimously passed House Bill 0484 that would expand coverage of biomarker testing for patients facing a variety of diseases including cancer. “ACS CAN applauds the passage of HB0484 in the House and appreciates the ... Society Cancer Action Network (ACS CAN) Tennessee Government Relations Director Maddie Michael said. “In the case of a cancer diagnosis, biomarker testing helps doctors determine the right treatment path, saving some patients from treatments that may not work and waste time. It also ...

Final NYS Budget Preserves Biomarker Testing Access

After months of debate, state lawmakers have finalized New York’s state budget, opting to preserve access to biomarker testing for Medicaid enrollees. The adopted budget changed language in the historic biomarker testing law, initially passed in 2023, to clarify biomarker testing is covered when it is medically necessary. The law will retain ...

Preserve Medicaid Patient Access To Biomarker Testing

Reject Governor Hochul's proposal to roll back important Medicaid coverage for biomarker testing.  State lawmakers must reject Governor Hochul’s proposed rollback of biomarker testing access for Medicaid patients. Biomarker testing saves lives and reduces long-term health care spending. The 2023 law, passed with ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy